{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:00:52Z","timestamp":1648990852399},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1007\/bf01700275","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T20:30:07Z","timestamp":1118435407000},"page":"213-221","source":"Crossref","is-referenced-by-count":4,"title":["Hematopoietic growth factors and the treatment of tumor-associated anemias"],"prefix":"10.1007","volume":"69","author":[{"given":"U.","family":"D\u00fchrsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. K.","family":"Hossfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 8","key":"BF01700275_CR1","first-page":"29","volume":"19","author":"RI Abels","year":"1992","unstructured":"Abels RI (1992) Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol 19 [Suppl 8]: 29\u201335","journal-title":"Semin Oncol"},{"issue":"Suppl","key":"BF01700275_CR2","first-page":"92a","volume":"82","author":"R Abels","year":"1993","unstructured":"Abels R, Larholt K, Nelson R, Young D (1993) Prediction of response to recombinant human erythropoietin therapy in anemic cancer patients. Blood 82 [Suppl]:92a","journal-title":"Blood"},{"key":"BF01700275_CR3","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/1097-0142(19910515)67:10+<2708::AID-CNCR2820671707>3.0.CO;2-A","volume":"67","author":"JW Adamson","year":"1991","unstructured":"Adamson JW (1991) Cytokine biology: applications for transfusion medicine. Cancer 67:2708\u20132711","journal-title":"Cancer"},{"key":"BF01700275_CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V72.2.705.705","volume":"72","author":"JH Antin","year":"1988","unstructured":"Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase-I\/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodys-plastic syndrome. Blood 72:705\u2013713","journal-title":"Blood"},{"key":"BF01700275_CR5","first-page":"1969","volume-title":"Wintrobe's clinical hematology","author":"JW Athens","year":"1993","unstructured":"Athens JW (1993) Chronic myeloid leukemia. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 1969\u20131998","edition":"9th edn"},{"key":"BF01700275_CR6","first-page":"2018","volume-title":"Wintrobe's clinical hematology","author":"JW Athens","year":"1993","unstructured":"Athens JW (1993) Myelofibrosis. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 2018\u20132033","edition":"9th edn"},{"key":"BF01700275_CR7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2141.1989.tb07733.x","volume":"72","author":"G Birgegard","year":"1989","unstructured":"Birgegard G, Wide L, Simonsson B (1989) Marked erythro-poietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation. Br J Haematol 72:462\u2013466","journal-title":"Br J Haematol"},{"key":"BF01700275_CR8","first-page":"136","volume-title":"Erythropoietin in renal and non-renal anemias","author":"J Bommer","year":"1991","unstructured":"Bommer J, Barth H-P, Zeier M, Mandelbaum A, Bommer G, Ritz E, Reichel H, Novack R (1991) Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L (eds) Erythropoietin in renal and non-renal anemias. Karger, Basel, pp 136\u2013143"},{"key":"BF01700275_CR9","first-page":"852","volume-title":"Wintrobe's clinical hematology","author":"SS Bottomley","year":"1993","unstructured":"Bottomley SS (1993) Sideroblastic anemias. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 852\u2013871","edition":"9th edn"},{"key":"BF01700275_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0609.1990.tb00343.x","volume":"44","author":"DT Bowen","year":"1990","unstructured":"Bowen DT, Jacobs A, Mary P, Cotes, Lewis TC (1990) Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Eur J Haematol 44:30\u201332","journal-title":"Eur J Haematol"},{"key":"BF01700275_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2141.1991.tb08594.x","volume":"77","author":"D Bowen","year":"1991","unstructured":"Bowen D, Culligan D, Jacobs A (1991) The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br J Haematol 77:419\u2013423","journal-title":"Br J Haematol"},{"key":"BF01700275_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0609.1991.tb00540.x","volume":"46","author":"HK Boyd","year":"1991","unstructured":"Boyd HK, Lappin TRJ (1991) Erythropoietin deficiency in the anaemia of chronic disorders. Eur J Haematol 46:198\u2013201","journal-title":"Eur J Haematol"},{"key":"BF01700275_CR13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1200\/JCO.1990.8.6.949","volume":"8","author":"HF Bunn","year":"1990","unstructured":"Bunn HF (1990) Editorial: Recombinant erythropoietin therapy in cancer patients. J Clin Oncol 8:949\u2013951","journal-title":"J Clin Oncol"},{"key":"BF01700275_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jnci\/85.10.801","volume":"85","author":"DC Case","year":"1993","unstructured":"Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, Salmon SE, Silver RT, Storniolo AM, Wampler GL, Dooley CM, Larholt KM, Nelson RA, Abels RI (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85:801\u2013806","journal-title":"J Natl Cancer Inst"},{"key":"BF01700275_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.1982.tb01890.x","volume":"50","author":"M Cazzola","year":"1982","unstructured":"Cazzola M, Barosi G, Berzuini C, Dacco M, Orlandi E, Stefanelli M, Ascari E (1982) Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol 50:55\u201362","journal-title":"Br J Haematol"},{"key":"BF01700275_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V79.1.29.29","volume":"79","author":"M Cazzola","year":"1992","unstructured":"Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase-I\/II clinical trial. Blood 79:29\u201337","journal-title":"Blood"},{"key":"BF01700275_CR17","first-page":"1946","volume-title":"Wintrobe's clinical hematology","author":"A Deiss","year":"1993","unstructured":"Deiss A (1993) Non-neoplastic diseases, chemical agents, and hematologic disorders that may precede hematologic neoplasms. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 1946\u20131968","edition":"9th edn"},{"key":"BF01700275_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-8140(91)90184-I","volume":"20","author":"S Dische","year":"1991","unstructured":"Dische S (1991) Radiotherapy and anemia \u2014 the clinical experience. Radiother Oncol 20:35\u201340","journal-title":"Radiother Oncol"},{"key":"BF01700275_CR19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM199105093241907","volume":"324","author":"AJ Erslev","year":"1991","unstructured":"Erslev AJ (1991) Drug therapy: erythropoietin. N Engl J Med 324:1339\u20131344","journal-title":"N Engl J Med"},{"issue":"Suppl 8","key":"BF01700275_CR20","first-page":"14","volume":"19","author":"AJ Erslev","year":"1992","unstructured":"Erslev AJ (1992) The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin. Semin Oncol 19 [Suppl 8]:14\u201318","journal-title":"Semin Oncol"},{"key":"BF01700275_CR21","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199005243222103","volume":"322","author":"M Fischl","year":"1990","unstructured":"Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA (1990) Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488\u20131493","journal-title":"N Engl J Med"},{"key":"BF01700275_CR22","first-page":"63","volume-title":"Hematopoiesis. Long-term effects of chemotherapy and radiation","author":"RP Gale","year":"1988","unstructured":"Gale RP (1988) Myelosuppressive effects of antineoplastic chemotherapy. In: Testa NG, Gale RP (eds) Hematopoiesis. Long-term effects of chemotherapy and radiation. Marcel Dekker, New York, pp 63\u201373"},{"key":"BF01700275_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-8588(18)30333-2","volume":"6","author":"A Ganser","year":"1992","unstructured":"Ganser A, Hoelzer D (1992) Treatment of myelodysplastic syndromes with hematopoietic growth factors. Hematol Oncol Clin North Am 6:633\u2013653","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF01700275_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V73.1.31.31","volume":"73","author":"A Ganser","year":"1989","unstructured":"Ganser A, V\u00f6lkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes \u2014 a phase-I\/II trial. Blood 73:31\u201337","journal-title":"Blood"},{"key":"BF01700275_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V76.3.455.455","volume":"76","author":"A Ganser","year":"1990","unstructured":"Ganser A, Seipelt G, Lindemann A, Ottmann OG, Falk S, Eder M, Herrmann F, Becher R, H\u00f6ffken K, B\u00fcchner T, Klausmann M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D (1990) Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 76:455\u2013462","journal-title":"Blood"},{"issue":"Suppl","key":"BF01700275_CR26","first-page":"377a","volume":"82","author":"A Ganser","year":"1993","unstructured":"Ganser A, Ottmann OG, Schadeck-Gressel C, Kolbe K, Haas R, Seipelt G, Maurer A, Zander C, Reutzel R, Hoelzer D (1993) Combination therapy with all-trans retinoic acid (ATRA), granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO) and vitamin E in patients with myelo-dysplastic syndromes (MDS). Blood 82 [Suppl]:377a","journal-title":"Blood"},{"key":"BF01700275_CR27","first-page":"696","volume":"7","author":"A Ganser","year":"1993","unstructured":"Ganser A, Ottmann OG, Seipelt G, Lindemann A, Hess U, Geissler G, Maurer A, Frisch F, Schulz G, Mertelsmann R, Hoelzer D (1993) Effect of long-term treatment with recom-binant human interleukin-3 in patients with myelodysplastic syndromes. Leukemia 7:696\u2013701","journal-title":"Leukemia"},{"key":"BF01700275_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.2830440403","volume":"44","author":"PB Hansen","year":"1993","unstructured":"Hansen PB, Johnsen HE, Hippe E, Hellstr\u00f6m-Lindberg E, Ralfkiaer E (1993) Recombinant human granulocyte-macro-phage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes. Am J Hematol 44:229\u2013236","journal-title":"Am J Hematol"},{"key":"BF01700275_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0609.1991.tb01860.x","volume":"47","author":"E Hellstr\u00f6m","year":"1991","unstructured":"Hellstr\u00f6m E, Birgegard G, Lockner D, Helmers C, \u00d6st A, Wide L (1991) Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol 47:355\u2013360","journal-title":"Eur J Haematol"},{"key":"BF01700275_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10428199309086999","volume":"11","author":"E Hellstr\u00f6m-Lindberg","year":"1993","unstructured":"Hellstr\u00f6m-Lindberg E, Birgegard G, Carlsson M, Carneskog J, Dahl IM, Dybedal I, Grimfors G, Merk K, Tangen JM, Winqvist I, \u00d6st A (1993) A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve anaemia in patients with myelodysplastic syndromes. Leuk Lymph 11:221\u2013228","journal-title":"Leuk Lymph"},{"issue":"Supp","key":"BF01700275_CR31","first-page":"376a","volume":"82","author":"E Hellstr\u00f6m-Lindberg","year":"1993","unstructured":"Hellstr\u00f6m-Lindberg E, Carlsson M, Grimfors G, Lindemalm C, L\u00f6fvenberg E, Tangen JM, \u00d6st A (1993) The combination of granulocyte-CSF and erythropoietin (EPO) may significantly increase the hemoglobin levels in MDS patients with no response to EPO alone. Report from a randomized phase-II trial. Blood 82 [Supp]:376a","journal-title":"Blood"},{"issue":"Suppl 8","key":"BF01700275_CR32","first-page":"3","volume":"19","author":"DH Henry","year":"1992","unstructured":"Henry DH (1992) Changing patterns of care in the management of anemia. Semin Oncol 19 [Suppl 8]:3\u20137","journal-title":"Semin Oncol"},{"issue":"Suppl 1","key":"BF01700275_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000204783","volume":"87","author":"WH H\u00f6rl","year":"1992","unstructured":"H\u00f6rl WH (1992) Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous. Acta Haematol 87 [Suppl 1]:16\u201319","journal-title":"Acta Haematol"},{"key":"BF01700275_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0140-6736(91)90863-K","volume":"337","author":"S Iki","year":"1991","unstructured":"Iki S, Yagisawa M, Ohbayashi Y, Sato H, Urabe A (1991) Adverse effect of erythropoietin in myeloproliferative disorders. Lancet 337:187\u2013188","journal-title":"Lancet"},{"key":"BF01700275_CR35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jcp.38.11.1201","volume":"38","author":"A Jacobs","year":"1985","unstructured":"Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 38:1201\u20131217","journal-title":"J Clin Pathol"},{"key":"BF01700275_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.1989.tb00215.x","volume":"73","author":"A Jacobs","year":"1989","unstructured":"Jacobs A, Janowska-Wieczorek A, Caro J, Bowen DT, Lewis T (1989) Circulating erythropoietin in patients with myelodysplastic syndromes. Br J Haematol 73:36\u201339","journal-title":"Br J Haematol"},{"key":"BF01700275_CR37","first-page":"284","volume":"23","author":"HP Koeffler","year":"1986","unstructured":"Koeffler HP (1986) Myelodysplastic syndromes (preleukemia). Semin Hematol 23:284\u2013299","journal-title":"Semin Hematol"},{"key":"BF01700275_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","volume":"77","author":"SB Krantz","year":"1991","unstructured":"Krantz SB (1991) Erythropoietin. Blood 77:419\u2013434","journal-title":"Blood"},{"key":"BF01700275_CR39","first-page":"985","volume":"5","author":"R Kurzrock","year":"1991","unstructured":"Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU (1991) Erythropoietin treatment in patients with myelodysplastic syndromes and anemia. Leukemia 5:985\u2013990","journal-title":"Leukemia"},{"key":"BF01700275_CR40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1200\/JCO.1991.9.7.1241","volume":"9","author":"R Kurzrock","year":"1991","unstructured":"Kurzrock R, Talpaz M, Estrov Z, Rosenblum MG, Gutterman JU (1991) Phase-I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol 9:1241\u20131250","journal-title":"J Clin Oncol"},{"key":"BF01700275_CR41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0360-3016(93)90536-5","volume":"27","author":"RS Lavey","year":"1993","unstructured":"Lavey RS, Dempsey WH (1993) Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 27:1147\u20131152","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF01700275_CR42","first-page":"61","volume":"20","author":"GR Lee","year":"1983","unstructured":"Lee GR (1983) The anemia of chronic disease. Semin Hematol 20:61\u201380","journal-title":"Semin Hematol"},{"key":"BF01700275_CR43","first-page":"840","volume-title":"Wintrobe's clinical hematology","author":"GR Lee","year":"1993","unstructured":"Lee GR (1993) The anemia of chronic disorders. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 840\u2013851","edition":"9th edn"},{"key":"BF01700275_CR44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM199207023270106","volume":"327","author":"GJ Lieschke","year":"1992","unstructured":"Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts). N Engl J Med 327:28\u201335","journal-title":"N Engl J Med"},{"key":"BF01700275_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199207093270207","volume":"327","author":"GJ Lieschke","year":"1992","unstructured":"Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (second of two parts). N Engl J Med 327:99\u2013106","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"BF01700275_CR46","first-page":"377a","volume":"82","author":"AL List","year":"1993","unstructured":"List AL, Noyes W, Power J, Thomas T, Glinsman-Gibson B, Taetle R, Miller-McCauley V, Gross M, Miller AM (1993) Combined treatment of myelodysplastic syndromes (MDS) with recombinant human interleukin-3 (IL-3) and erythropoietin (EPO). Blood 82 [Suppl]:377a","journal-title":"Blood"},{"key":"BF01700275_CR47","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","volume":"322","author":"H Ludwig","year":"1990","unstructured":"Ludwig H, Fritz E, Kotzmann H, H\u00f6cker P, Gisslinger H, Bamas U (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1693\u20131699","journal-title":"N Engl J Med"},{"key":"BF01700275_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.annonc.a058423","volume":"4","author":"H Ludwig","year":"1993","unstructured":"Ludwig H, Fritz E, Leitgeb C, Krainer M, K\u00fchrer I, Sagaster P, Umek H (1993) Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann Oncol 4:161\u2013167","journal-title":"Ann Oncol"},{"key":"BF01700275_CR49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/gyno.1993.1102","volume":"49","author":"M Markman","year":"1993","unstructured":"Markman M, Reichman B, Hakes T, Rubin S, Jones W, Lewis JL, Barakat R, Curtin J, Almadrones L, Hoskins W (1993) The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. Gynecol Oncol 49:172\u2013176","journal-title":"Gynecol Oncol"},{"key":"BF01700275_CR50","first-page":"771","volume":"4","author":"S Merchav","year":"1990","unstructured":"Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L (1990) In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia 4:771\u2013774","journal-title":"Leukemia"},{"key":"BF01700275_CR51","volume-title":"The hemopoietic colony-stimulating factors","author":"D Metcalf","year":"1984","unstructured":"Metcalf D (1984) The hemopoietic colony-stimulating factors. Elsevier, Amsterdam"},{"key":"BF01700275_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/339027a0","volume":"339","author":"D Metcalf","year":"1989","unstructured":"Metcalf D (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27\u201330","journal-title":"Nature"},{"key":"BF01700275_CR53","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199006143222401","volume":"322","author":"CB Miller","year":"1990","unstructured":"Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689\u20131692","journal-title":"N Engl J Med"},{"key":"BF01700275_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jnci\/84.2.98","volume":"84","author":"CB Miller","year":"1992","unstructured":"Miller CB, Platanias LC, Mills SR, Zahurak ML, Ratain MJ, Ettinger DS, Jones RJ (1992) Phase I\u2013II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 84:98\u2013103","journal-title":"J Natl Cancer Inst"},{"key":"BF01700275_CR55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V76.1.36.36","volume":"76","author":"RS Negrin","year":"1990","unstructured":"Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76:36\u201343","journal-title":"Blood"},{"key":"BF01700275_CR56","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood.V82.3.737.737","volume":"82","author":"RS Negrin","year":"1993","unstructured":"Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL (1993) Treatment of the anemia of myelodysplastic syndromes using human granulocyte colonystimulating factor in combination with erythropoietin. Blood 82:737\u2013743","journal-title":"Blood"},{"key":"BF01700275_CR57","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.1990.8.6.956","volume":"8","author":"W Oster","year":"1990","unstructured":"Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, M\u00fcller G, Brune T, Kraemer H-P, Mertelsmann R (1990) Erythropoietin for the treatment of anemia associated with neoplastic bone marrow infiltration. J Clin Oncol 8:956\u2013962","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"BF01700275_CR58","first-page":"574a","volume":"82","author":"GA Pangalis","year":"1993","unstructured":"Pangalis GA, Poziopoulos C, Panayiotidis P, Angelopoulou M (1993) Treatment of anaemia in B-chronic lymphocytic leukemia (B-CLL) with recombinant human erythropoietin (r-HuEPO). Blood 82 [Suppl]:574a","journal-title":"Blood"},{"key":"BF01700275_CR59","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1200\/JCO.1991.9.11.2021","volume":"9","author":"LC Platanias","year":"1991","unstructured":"Platanias LC, Miller CB, Mick R, Hart RD, Ozer H, McEvilly J-M, Jones RJ, Ratain MJ (1991) Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol 9:2021\u20132026","journal-title":"J Clin Oncol"},{"key":"BF01700275_CR60","first-page":"494","volume":"77","author":"L Ponchio","year":"1992","unstructured":"Ponchio L, Beguin Y, Farina G, Pedrazzoli P, Pedrotti C, Poggi G, Rosti V, Bergamaschi G, Battistel V, Cazzola M (1992) Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anemia. Haematologica (Pavia) 77:494\u2013501","journal-title":"Haematologica (Pavia)"},{"key":"BF01700275_CR61","first-page":"323","volume":"6","author":"D Rafanelli","year":"1992","unstructured":"Rafanelli D, Grossi A, Longo G, Vannucchi AM, Bacci P, Ferrini PR (1992) Recombinant human erythropoietin for the treatment of myelodysplastic syndromes. Leukemia 6:323\u2013327","journal-title":"Leukemia"},{"key":"BF01700275_CR62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0092-8674(91)90643-D","volume":"64","author":"CL Sawyers","year":"1991","unstructured":"Sawyers CL, Denny CT, Witte ON (1991) Leukemia and the disruption of normal hemopoiesis. Cell 64:337\u2013350","journal-title":"Cell"},{"key":"BF01700275_CR63","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V76.11.2354.2354","volume":"76","author":"L Schapira","year":"1990","unstructured":"Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, McGarigle CJ, Goldberg MA (1990) Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 76:2354\u20132359","journal-title":"Blood"},{"key":"BF01700275_CR64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/0003-4819-115-7-572","volume":"115","author":"RF Schilling","year":"1991","unstructured":"Schilling RF (1991) Anemia of chronic disease: a misnomer. Ann Intern Med 115:572\u2013573","journal-title":"Ann Intern Med"},{"key":"BF01700275_CR65","first-page":"432","volume":"5","author":"HC Schouten","year":"1991","unstructured":"Schouten HC, Vellenga E, Van Rhenen DJ, De Wolf JTM, Coppens PJW, Blijham GH (1991) Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 5:432\u2013436","journal-title":"Leukemia"},{"key":"BF01700275_CR66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.1993.tb03157.x","volume":"84","author":"G Seipelt","year":"1993","unstructured":"Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D (1993) Induction of TNF-\u03b1 in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Br J Haematol 84:749\u2013751","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"BF01700275_CR67","first-page":"93a","volume":"82","author":"BS Skikne","year":"1993","unstructured":"Skikne BS, Ahluwalia N, Savin V, Chonko A, Cook JD (1993) Serum transferrin receptor (TfR) and automated reticulocyte counts are early markers of marrow response to recombinant human erythropoietin (rHuEPO). Blood 82 [Suppl]:93a","journal-title":"Blood"},{"key":"BF01700275_CR68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00000421-199302000-00006","volume":"16","author":"JR Skillings","year":"1993","unstructured":"Skillings JR, Sridhar FG, Wong C, Paddock L (1993) The frequency of red cell transfusion for anemia in patients receiving chemotherapy. Am J Clin Oncol (CCT) 16:22\u201325","journal-title":"Am J Clin Oncol (CCT)"},{"key":"BF01700275_CR69","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","volume":"78","author":"RS Stein","year":"1991","unstructured":"Stein RS, Abels RI, Krantz SB (1991) Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 78:1658\u20131663","journal-title":"Blood"},{"key":"BF01700275_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(93)90122-3","volume":"70","author":"S Suciu","year":"1993","unstructured":"Suciu S, Zeller W, Weh HJ, Hossfeld DK (1993) Immunophe-notype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemia. Cancer Genet Cytogenet 70:1\u20135","journal-title":"Cancer Genet Cytogenet"},{"key":"BF01700275_CR71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JCO.1989.7.5.629","volume":"7","author":"JA Thompson","year":"1989","unstructured":"Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, Bonnem EM, Fefer A (1989) Subcutaneous granulocyte-macro-phage colony-stimulating factor in patients with myelodys-plastic syndrome: toxicity, pharmakokinetics, and hematological effects. J Clin Oncol 7:629\u2013637","journal-title":"J Clin Oncol"},{"key":"BF01700275_CR72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF01789131","volume":"36","author":"M Tsukuda","year":"1993","unstructured":"Tsukuda M, Mochimatsu I, Nagahara T, Kokatsu T, Sawaki S, Kubota A, Furkawa M, Arai Y (1993) Clinical application of recombinant human erythropoietin for treatments in patients with head and neck cancer. Cancer Immunol Immunother 36:52\u201356","journal-title":"Cancer Immunol Immunother"},{"key":"BF01700275_CR73","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","volume":"317","author":"S Vadhan-Raj","year":"1987","unstructured":"Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317:1545\u20131552","journal-title":"N Engl J Med"},{"key":"BF01700275_CR74","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V75.8.1749.1749","volume":"75","author":"S Vadhan-Raj","year":"1990","unstructured":"Vadhan-Raj S, Hittelman WN, Lepe-Zuniga JL, Gutterman JU, Broxmeyer HE (1990) Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes. Blood 75:1749\u20131750","journal-title":"Blood"},{"key":"BF01700275_CR75","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1991.tb04477.x","volume":"78","author":"H Kamp Van","year":"1991","unstructured":"Van Kamp H, Prinsze-Postema TC, Kluin PM, Den Ottolander GJ, Beverstock GC, Willemze R, Fibbe WE (1991) Effect of subcutaneously administered human recombinant erythro-poietin on erythropoiesis in patients with myelodysplasia. Br J Haematol 78:488\u2013493","journal-title":"Br J Haematol"},{"key":"BF01700275_CR76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01811466","volume":"64","author":"GEG Verhoef","year":"1992","unstructured":"Verhoef GEG, Zach\u00e9e P, Ferrant A, Demuynck H, Selleslag D, Van Hove L, Deckers F, Boogaerts MA (1992) Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment. Ann Hematol 64:16\u201321","journal-title":"Ann Hematol"},{"issue":"Suppl","key":"BF01700275_CR77","first-page":"377a","volume":"82","author":"G Verhoef","year":"1993","unstructured":"Verhoef G, Demuynck H, Zach\u00e9e P, Ceuppens J, Dewitte M, Boogaerts M (1993) Treatment of myelodysplastic syndromes (MDS) with the combination of interleukin-3 and erythro-poietin. Blood 82 [Suppl]: 377a","journal-title":"Blood"},{"key":"BF01700275_CR78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0360-3016(93)90299-B","volume":"26","author":"S Vijayakumar","year":"1993","unstructured":"Vijayakumar S, Roach M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan A, Houghton A, Quiet C, Weichselbaum R (1993) Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-label phase-II trial. Int J Radiat Oncol Biol Phys 26:721\u2013729","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF01700275_CR79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.1991.tb04451.x","volume":"78","author":"Y Yoshida","year":"1991","unstructured":"Yoshida Y, Hirashima K, Asano S, Takaku F (1991) A phase-II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br J Haematol 78:378\u2013384","journal-title":"Br J Haematol"},{"key":"BF01700275_CR80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01703232","volume":"66","author":"Y Yoshida","year":"1993","unstructured":"Yoshida Y, Anzai N, Kawabata H, Kohsaka Y, Okuma M (1993) Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment. Ann Hematol 66:175\u2013180","journal-title":"Ann Hematol"},{"key":"BF01700275_CR81","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.1993.tb04626.x","volume":"83","author":"ZR Zeigler","year":"1993","unstructured":"Zeigler ZR, Rosenfeld CS, Shadduck RK (1993) Resolution of transfusion dependence by recombinant human erythro-poietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia. Br J Haematol 83:28\u201329","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01700275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01700275\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01700275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T16:13:28Z","timestamp":1586276008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01700275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["BF01700275"],"URL":"https:\/\/doi.org\/10.1007\/bf01700275","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}